CNS Pharmaceuticals reports Q2 results

1 hour ago 1

CNS Pharmaceuticals press release (NASDAQ:CNSP): Q2
The net loss for the three months ended June 30, 2025 was approximately $2.4 million compared to approximately $2.5 million for the comparable period in 2024. The change in net loss is largely attributable to

Recommended For You